egtazic acid has been researched along with s-nitro-n-acetylpenicillamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hassid, A; Kaur, K; Matthews, C; Pan, X; Yao, J | 1 |
| Bolotina, VM; Cohen, RA; Mongayt, DA; Zakharov, SI | 1 |
| Hansford, R; Khan, L; Lakatta, EG; Longo, DL; Sollott, SJ; Srivastava, RK | 1 |
| Maruyama, I; Nakata, M; Uto, N; Yada, T | 1 |
| Dongre, N; Eisenach, JC; Li, X; Pan, HL; Rose, G; Tobin, JR | 1 |
| Jeong, HS; Park, JS | 1 |
| Iida, H; Inoue, N; Ishida, H; Ishikawa, Y; Yuan, Z | 1 |
7 other study(ies) available for egtazic acid and s-nitro-n-acetylpenicillamine
| Article | Year |
|---|---|
NO decreases phosphorylation of focal adhesion proteins via reduction of Ca in rat aortic smooth muscle cells.
Topics: Animals; Calcimycin; Calcium; Cells, Cultured; Chelating Agents; Cortactin; Cytoskeletal Proteins; Egtazic Acid; Enzyme Activation; Female; Ionophores; Microfilament Proteins; Muscle, Smooth, Vascular; Nitric Oxide; Paxillin; Penicillamine; Phosphoproteins; Phosphorylation; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley | 1998 |
Monovalent cation and L-type Ca2+ channels participate in calcium paradox-like phenomenon in rabbit aortic smooth muscle cells.
Topics: 4-Aminopyridine; Animals; Aorta; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cations, Monovalent; Cesium; Chelating Agents; Egtazic Acid; Glutamine; Imidazoles; Lithium; Magnesium; Membrane Potentials; Muscle, Smooth, Vascular; Nifedipine; Patch-Clamp Techniques; Penicillamine; Potassium; Rabbits; Sodium; Tetraethylammonium; Vasoconstriction | 1999 |
Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis.
Topics: Apoptosis; bcl-X Protein; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Calcium-Transporting ATPases; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Egtazic Acid; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Mitochondria; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligopeptides; Penicillamine; Proto-Oncogene Proteins c-bcl-2; Thapsigargin | 1999 |
Nitric oxide induces apoptosis via Ca2+-dependent processes in the pancreatic beta-cell line MIN6.
Topics: Animals; Apoptosis; Calcium; Cell Survival; Chelating Agents; Diabetes Mellitus, Type 1; Egtazic Acid; Insulinoma; Islets of Langerhans; Mice; Nitric Oxide; Nitric Oxide Donors; Pancreas; Pancreatic Neoplasms; Penicillamine; Tumor Cells, Cultured | 1999 |
S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes.
Topics: Adrenergic Uptake Inhibitors; Animals; Binding, Competitive; Calcium; Calmodulin; Cysteine; Desipramine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Egtazic Acid; Leucine; Magnesium; Male; Nickel; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Nomifensine; Norepinephrine; omega-Conotoxins; Penicillamine; Rats; Rats, Sprague-Dawley; S-Nitrosothiols; Sodium; Spinal Cord; Synaptosomes | 2000 |
Effects of nitric oxide on the vestibular functional recovery after unilateral labyrinthectomy.
Topics: Animals; Cyclic GMP; Ear, Inner; Egtazic Acid; Enzyme Inhibitors; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Nystagmus, Physiologic; Penicillamine; Potassium Channels; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Vestibular Nuclei | 2000 |
Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice.
Topics: Alkaloids; Amylases; Animals; Azepines; Benzoates; Benzylamines; Calcium; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; Carbazoles; Chelating Agents; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Estrenes; Gallic Acid; Genotype; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Indoles; Male; Mice; Mice, Knockout; Molsidomine; Muscarinic Agonists; Myosin-Light-Chain Kinase; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxadiazoles; Parotid Gland; Penicillamine; Phosphodiesterase Inhibitors; Pilocarpine; Protein Kinase Inhibitors; Pyrroles; Pyrrolidinones; Quinoxalines; Quinuclidines; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Type C Phospholipases | 2003 |